載入...
A Potential Mechanism of Temozolomide Resistance in Glioma–Ferroptosis
Temozolomide (TMZ) is the first-line chemotherapy drug that has been used to treat glioma for over a decade, but the benefits are limited by half of the treated patients who acquired resistance. Studies have shown that glioma TMZ resistance is a complex process with multiple factors, which has not b...
Na minha lista:
| 發表在: | Front Oncol |
|---|---|
| Main Authors: | , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
Frontiers Media S.A.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7324762/ https://ncbi.nlm.nih.gov/pubmed/32656078 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fonc.2020.00897 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|